Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Tumori|September 23, 2015
Beyond the beyond: first case of 9 cytoreductive surgeries in a long-surviving ovarian cancer patient: case reportLaura Salerno, Claudia Marchetti, Elisa Bevilacqua, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2025
Extending the timing for secondary cytoreductive surgery after second-line chemotherapy in relapsed ovarian cancer: the EXTENSION studyCarmine Conte, Luigi Congedo, Claudia Marchetti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 22, 2022
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenanceEleonora Palluzzi, Claudia Marchetti, Serena Cappuccio, et al.
Current Drug Targets|October 11, 2014
Cervical cancer: are there potential new targets? An update on preclinical and clinical resultsFederica Tomao, Chiara Di Tucci, Ludovica Imperiale, et al.
Molecular Biology Reports|May 30, 2020
High resolution melting profiles (HRMPs) obtained by magnetic induction cycler (MIC) have been used to monitor the BRCA2 status highlighted by next generation tumor sequencing (NGTS): a combined approach in a diagnostic environmentGiorgia Mazzuccato, Maria De Bonis, Vittoria Carboni, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 13, 2022
Nomogram to predict feasibility of minimally invasive interval debulking surgery in advanced ovarian cancerCarmine Conte, Andrea Rosati, Claudia Marchetti, et al.
Minerva Ginecologica|October 16, 2018
Management of endometriosis from diagnosis to treatment: roadmap for the futureLudovico Muzii, Chiara Di Tucci, Mara Di Feliciantonio, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 24, 2025
Efficacy of Neoadjuvant Chemotherapy as pre-habilitation program in advanced epithelial ovarian cancerValentina Ghirardi, Claudia Marchetti, Diana Giannarelli, et al.
Oncotarget|August 11, 2016
Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysisClaudia Marchetti, Francesca De Felice, Angela Musella, et al.
Critical Reviews in Oncology/Hematology|November 8, 2011
Current knowledge and open issues regarding bevacizumab in gynaecological neoplasmsFilippo Bellati, Chiara Napoletano, Maria Luisa Gasparri, et al.
Pageof 18